Co-authored by VHIO investigators, primary results from the multicenter TROPiCS-02 study of novel antibody-drug conjugate (ADC) sacituzumab govitecan in patients with hormone receptor-positive/HER2...
Read more
Presented by Ana Oaknin, Principal Investigator of VHIO’s Gynecological Malignancies Group, during this week’s American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June 2022,...
Read more
La investigación abre una puerta a una posible solución para las pacientes que desarrollan resistencia a la terapia anti-HER2, que ocurre en un 20%-25% de los casos, dando lugar a un estadio de la e...
Read more
A pioneering treatment for Polycystic Ovary Syndrome is beginning to be evaluated in Girona and Barcelona through an international clinical trial, within the framework of a European project called SPI...
Read more
El grupo del Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca) especializado en segregación cromosómica y enfermedades humanas, liderado por Alberto M. Pendás y Elena Llano, acab...
Read more
A new study co-led by the Dr. Lupu lab at the Mayo Clinic in the United States and the ICO-IDIBGI “Metabolism and Cancer” group has just discovered that the growth factor heregulin –a known indu...
Read more
The objective was to collaborate to identify the chromosomal regions affected by anomalies in T-47D breast cancer cell culture. These are the most commonly used cells by the worldwide scientific commu...
Read more
La Recuperación Intensificada en Cirugía consigue que el proceso perioperatori de las pacientes de ginecología oncológica mejore, acortando la estancia hospitalaria, los reingresos, las complicaci...
Read more
Los resultados del proyecto contribuirán a la iniciativa internacional Human Cell Atlas para redefinir la anatomía humana a nivel de célula única y proporcionarán una visión sin precedentes de e...
Read more
Dos estudios del Hospital del Mar demuestran que este sistema es el preferido por las mujeres. Les genera menos incomodidad y, a la vez, permite obtener unos resultados igual de buenos que con la tecn...
Read more
On 13 May 2022, the conformity assessment for the unique in vitro diagnostic medical device MAFTEST® developed by Inbiomotion was completed and the declaration of conformity was drawn up.
Read more
A project led by Roni Wright, alumni of the Centre for Genomic Regulation (CRG) and currently at the International University of Catalonia (UIC Barcelona), is one of fifteen initiatives chosen in the ...
Read more
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Regenera Activa Worldwide and Rigenera HBW, biotech firms specializing...
